Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PCC RokitaWAR:PCR -1.90%81 EV-to-EBIT is 19.79 as of Aug. 06, 2026, which is 114% above its 10-year median of 9.25. GuruFocus rates WAR:PCR with a GF Score™ of 81/100 and a GF Value™ of zł66.74 (Fairly Valued). The stock has 8 warning signs investors should review. Among 1,242 Chemicals companies, PCC Rokita ranks worse than 55.64% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
PCC Rokita's Enterprise Value for the quarter that ended in Mar. 2026 was zł1,811 Mil.
PCC Rokita's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł92 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PCC Rokita EV-to-EBIT Related Terms
PCC Rokita EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for PCC Rokita's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, PCC Rokita's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PCC Rokita EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, PCC Rokita's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where PCC Rokita's EV-to-EBIT falls into.
PCC Rokita's current Enterprise Value is zł1,819 Mil.
PCC Rokita's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł92 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PCC Rokita (WAR:PCR) has a EV-to-EBIT of 19.79 as of Aug. 06, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on PCC Rokita and its competitors. This is 114% above median its historical median of 9.25. Over the past decade, PCC Rokita's EV-to-EBIT has ranged from 2.41 to 20.67. According to the industry distribution chart, PCC Rokita ranks #691 out of 1242 companies in the Chemicals industry, placing it in the top 55.6%.
Is PCC Rokita's EV-to-EBIT too high?
PCC Rokita's current EV-to-EBIT of 19.79 is 114% above median its 10-year median of 9.25. Over the past 10 years, this metric has ranged from a low of 2.41 to a high of 20.67. The Chemicals industry median EV-to-EBIT is 17.53. PCC Rokita's value of 19.79 is 12.9% above this industry median. Based on the distribution chart, PCC Rokita ranks #691 out of 1242 companies in the Chemicals industry, which is below the industry midpoint. Overall, PCC Rokita has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PCC Rokita's EV-to-EBIT compare to DOW?
According to the Chemicals industry distribution chart, PCC Rokita ranks #691 out of 1242 companies for EV-to-EBIT. This places PCC Rokita in the lower half of its industry. The industry median EV-to-EBIT is 17.53. PCC Rokita's value of 19.79 is 12.9% above this benchmark. Historically, PCC Rokita's own EV-to-EBIT has ranged from 2.41 to 20.67 over the past decade. While the company's 10-year median is 9.25 vs. the industry median of 17.53, PCC Rokita has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 17.53, based on 1,242 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PCC Rokita's current EV-to-EBIT of 19.79 is 12.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on PCC Rokita and its competitors. For the Chemicals industry, the median EV-to-EBIT is 17.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PCC Rokita's current EV-to-EBIT is 19.79, which is 114% above median its own 10-year median of 9.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PCC Rokita stock overvalued right now?
Based on GuruFocus' analysis, PCC Rokita (WAR:PCR) is currently considered Fairly Valued. The stock's GF Value™ is zł66.74, compared to a current price of zł67.30 — trading 0.8% above its estimated fair value. The current EV-to-EBIT is 19.79, which is 114% above median its 10-year median of 9.25 and 12.9% above the Chemicals industry median of 17.53. PCC Rokita's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For PCC Rokita (WAR:PCR), the current EV-to-EBIT is 19.79 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PCC Rokita (WAR:PCR) Overvalued in 2026?
Based on GuruFocus' analysis, PCC Rokita stock appears to be overvalued.
The current stock price of zł67.30 is trading 0.8% above its estimated GF Value™ of zł66.74.
GuruFocus considers PCC Rokita to be Fairly Valued.
Key valuation signals for WAR:PCR:
EV-to-EBIT: 19.79 (114% above median its 10-year median of 9.25)
GF Value™: zł66.74 vs. price of zł67.30 (0.8% above fair value)
Industry Position: 12.9% above the Chemicals median (#691 of 1242)
No single metric tells the full story. See the WAR:PCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PCC Rokita SA is engaged in manufacturing chemicals. Its products include Polyols, Chloralkali, Chlorobenzene, Phosphorus derivatives, and Naphthalene derivatives. It serves adhesives, agrochemicals, building and construction, case, detergents, fire prevention, food and fuel industry, furniture, I&I cleaning, lubricants and functional fluids, metallurgical, mining and drilling, oilfield, paints and coatings, personal care, pharmaceuticals, plastics, power, printing ink, pulp and paper, raw materials and intermediates, refrigeration and household appliances, sports and recreation, tanning and textile, transportation, and water and wastewater treatment industries.
81GF Score
Get the complete analysis for WAR:PCR
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PCR has been successfully added to your 
